The Future of Pharmaceutical Manufacturing
We always talk about "the light at the end of the tunnel"... but have you ever wondered how is the tunnel built?
The future of pharmaceutical manufacturing can be shaped by us. The 2019 PD2M Future of Pharmaceutical Manufacturing Workshop will take place November 21-22, in Washington, D.C. This workshop will explore business, regulatory, and technical aspects associated with adopting novel manufacturing platforms. Invited speakers include Michael Kopcha, FDA; Paul Collins, Eli Lilly; Klavs Jensen, MIT; Tim Watson, Pfizer; James Coburn, FDA; Tom O’Connor, FDA; Sean Bermingham, PSE; Jon Dieringer, Eli Lilly; Jacob Albrecht, BMS; Laura Crowell, MIT; Ken Ford, Novartis; Martin McLoughlin, BMS; Martin Johnson, Eli Lilly; Jose Tabora, BMS; Salvador Garcia, Eli Lilly; Rex Reklaitis, Purdue University; Nima YazdanPanah, FDA; Fred Parietti, Multiply Labs; Luke Rogers, On Demand Pharmaceuticals
We look forward to seeing you in D.C.
Register here
Submit an abstract to our poster session here
Check out the preliminary program here
Become a sponsor or exhibitor here
Strategic Business Development Leader CDMO through Commercial: Pharma and Biotech Industries
5 年Sounds exciting -- quite a list of speakers.....a crystal ball would also be helpful ;)